首页|期刊导航|肿瘤学与转化医学（英文）|Histone modification as a drug resistance driver in brain tumors

Histone modification as a drug resistance driver in brain tumors

Guifa Xi Barbara Mania-Farnell Ting Lei Tadanori Tomita

肿瘤学与转化医学（英文）2016，Vol.2Issue(5)：216-226,11.

肿瘤学与转化医学（英文）2016，Vol.2Issue(5)：216-226,11.DOI:10.1007/s10330-016-0165-5

Histone modification as a drug resistance driver in brain tumors

Guifa Xi ¹Barbara Mania-Farnell ²Ting Lei ³Tadanori Tomita¹

作者信息

1. Falk Brain Tumor Center, Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, USA
2. Department of Biological Sciences, Purdue University Calumet, Hammond, USA
3. Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
折叠

摘要

关键词

histone modification/drug resistance/brain tumor

Key words

histone modification/drug resistance/brain tumor

引用本文复制引用

Guifa Xi,Barbara Mania-Farnell,Ting Lei,Tadanori Tomita..Histone modification as a drug resistance driver in brain tumors[J].肿瘤学与转化医学（英文）,2016,2(5):216-226,11.

基金项目

Supported by the Rory David Deutsch Foundation, the Surgical Neuro-oncology Research Fund of Ann & Robert H Lurie Children’s Hospi-tal (A&RLCH) of Chicago, and the Dr. Ralph and Marian C. Falk Medical Research Trust （A&RLCH）

肿瘤学与转化医学（英文）

OACSTPCD

ISSN：2095-9621

访问量4

下载量0

段落导航